Market News & Trends
8/15/2012
Quintiles Acquires Company to Advance Personalized Medicine Quintiles recently announced the acquisition of Expression Analysis, Inc. (EA), a premier provider of genomics testing and analysis…
8/8/2012
Researchers Discover New Mechanism Behind Resistance to Cancer Treatment Developing resistance to chemotherapy is a nearly universal, ultimately lethal consequence for cancer patients with solid…
Advantar Adds Executive Superhero
Advantar Laboratories, Inc. recently announced the addition of Dave Bergstrom, PhD, to the company's executive team as Chief Operating Officer. Dr. Bergstrom will be responsible…
Aptar's Dose Indicator Chosen for Allergic Rhinitis
ZETONNA (ciclesonide) Nasal Aerosol from Sunovion Pharmaceuticals Inc., equipped with an Aptar Pharma Landmark® dose indicator, is now available in the US for the treatment…
CoreRx, Inc. Opens State-of-the-Art Facility
CoreRx, Inc. recently announced it is now occupying its new 35,000-sq-ft facility in Clearwater, FL. This distinct facility will enable CoreRx's scientific staff to custom…
InSite Vision Initiates First Phase III Clinical Study
InSite Vision Incorporated recently announced that patient enrollment has begun in the first Phase III clinical trial of BromSite (ISV-303) for the reduction of pain…
Purac Acquires FiberLive Technology
Purac recently announced it has acquired the FiberLive technology from Vivoxid Ltd., Finland. The acquisition includes the intellectual property of the FiberLive technology and its…
Researchers Discover New Mechanism Behind Resistance to Cancer Treatment
Developing resistance to chemotherapy is a nearly universal, ultimately lethal consequence for cancer patients with solid tumors - such as those of the breast, prostate,…
Caisson Biotech Appoints New CEO & President
Caisson Biotech, L.L.C. recently announced it has appointed Glenn E. Nedwin, PhD, as Chief Executive Officer and President. Former Caisson CEO, Thomas Harlan, who is…
Catalent Supplies ODTs to Otsuka, Makes Extensive Investments in UK
Catalent recently announced it has commenced supply to Otsuka Pharmaceutical Co., Ltd. of Abilify OD Tablets (orally disintegrating tablets, ODTs), which utilize Catalent's Zydis fast-dissolve drug…
pSivida Announces Evaluation Agreement for Protein/Antibody Delivery System
pSivida Corp. recently announced it has signed a funded technology evaluation agreement with a leading global biopharmaceutical company to evaluate pSivida's Tethadur protein/antibody delivery technology…
8/1/2012
BD Launches Thin-Wall Needle Technology BD Medical recently announced the launch of the BD Hyflow needle, a unique 27-gauge thin-wall needle designed for use with…
Adoption of Prefillable Syringes Rising Notes Frost & Sullivan
The prefillable syringes (PFS) market in Europe is growing due to the convenience, efficiency, and safety PFS offers. There is an increasing use of PFS…
BD Launches Thin-Wall Needle Technology
BD Medical recently announced the launch of the BD Hyflow needle, a unique 27-gauge thin-wall needle designed for use with BD's prefillable syringe systems. The…
Biotech Investor Raises $2.6-Billion VC Fund
New Enterprise Associates, Inc. (NEA), a leading global venture capital firm, recently announced the official close of its fourteenth fund with $2.6 billion in total…
7/25/2012
Agile Therapeutics Raises $40 Million Agile Therapeutics recently announced it has closed a $40-million Series C financing. The round was led by new investor Aisling…
Agile Therapeutics Raises $40 Million
Agile Therapeutics recently announced it has closed a $40-million Series C financing. The round was led by new investor Aisling Capital, LLC, who joins existing…
Array BioPharma Reaches Multi-Million Dollar Milestone
Array BioPharma Inc. recently announced that an $8.5-million milestone was achieved in its collaboration with Amgen. Array entered into an agreement with Amgen in December…
BioTime Signs Agreements With Jade Therapeutics
BioTime, Inc. recently announced the signing of an exclusive sublicense agreement and a supply agreement with Jade Therapeutics, LLC, a developer of an ophthalmological therapeutic…
Infinity Pharmaceuticals Regains Worldwide Rights to Multiple Programs
Infinity Pharmaceuticals, Inc. recently announced it has restructured its strategic alliance with Mundipharma International Corporation Limited and Purdue Pharmaceutical Products L.P. by mutual agreement. With…
